Vaxart Inc (VXRT)
0.8977
-0.01
(-1.36%)
USD |
NASDAQ |
Apr 15, 16:00
0.8991
0.00 (0.00%)
Pre-Market: 08:29
Vaxart Price to Book Value: 2.70 for April 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 15, 2024 | 2.70 |
| April 12, 2024 | 2.737 |
| April 11, 2024 | 3.128 |
| April 10, 2024 | 3.038 |
| April 09, 2024 | 3.128 |
| April 08, 2024 | 3.248 |
| April 05, 2024 | 3.248 |
| April 04, 2024 | 3.399 |
| April 03, 2024 | 3.700 |
| April 02, 2024 | 3.730 |
| April 01, 2024 | 3.91 |
| March 28, 2024 | 3.91 |
| March 27, 2024 | 3.88 |
| March 26, 2024 | 3.669 |
| March 25, 2024 | 3.700 |
| March 22, 2024 | 3.790 |
| March 21, 2024 | 3.700 |
| March 20, 2024 | 3.730 |
| March 19, 2024 | 3.489 |
| March 18, 2024 | 3.489 |
| March 15, 2024 | 3.248 |
| March 14, 2024 | 3.308 |
| March 13, 2024 | 3.399 |
| March 12, 2024 | 3.429 |
| March 11, 2024 | 3.459 |
| Date | Value |
|---|---|
| March 08, 2024 | 3.579 |
| March 07, 2024 | 3.339 |
| March 06, 2024 | 3.504 |
| March 05, 2024 | 3.533 |
| March 04, 2024 | 3.577 |
| March 01, 2024 | 3.650 |
| February 29, 2024 | 3.562 |
| February 28, 2024 | 3.782 |
| February 27, 2024 | 3.708 |
| February 26, 2024 | 3.592 |
| February 23, 2024 | 3.708 |
| February 22, 2024 | 4.088 |
| February 21, 2024 | 4.117 |
| February 20, 2024 | 3.592 |
| February 16, 2024 | 3.490 |
| February 15, 2024 | 3.446 |
| February 14, 2024 | 3.460 |
| February 13, 2024 | 3.475 |
| February 12, 2024 | 3.650 |
| February 09, 2024 | 3.475 |
| February 08, 2024 | 3.446 |
| February 07, 2024 | 3.475 |
| February 06, 2024 | 3.504 |
| February 05, 2024 | 3.402 |
| February 02, 2024 | 3.504 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2939
Minimum
Sep 26 2019
46.01
Maximum
Jul 14 2020
4.221
Average
3.136
Median
Price to Book Value Benchmarks
| aTyr Pharma Inc | 1.270 |
| Allogene Therapeutics Inc | 1.172 |
| AIM ImmunoTech Inc | 2.534 |
| Protalix BioTherapeutics Inc | 2.481 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 14.02 |
| Price | 0.8977 |
| Earnings Yield | -64.61% |
| Market Cap | 156.08M |